Le Lézard
Classified in: Health
Subjects: PDT, PLW

Diba Industries, Inc. Announces Issuance of US Patent for Multistage Syringe Assembly


DANBURY, Conn., May 25, 2017 /PRNewswire/ -- Diba Industries, Inc., a leader in precision fluid handling solutions to global OEM leaders in diagnostics, life sciences and medical devices, announced today the issuance by the US Patent Office of a patent for a multistage syringe assembly. The patent for invention number 9,579,687 is the sixth patent award for Diba Industries.

The multi-stage syringe offers two chambers for widely varied dispense volumes with a single plunger. Precision dispense is enabled by a smaller glass chamber in the first stage of the syringe, while the second stage contains a larger gross dispense chamber that can be used to expedite a wash cycle or other application. A novel plunger design enables seamless operation between the two chambers.

The benefit of the multi-stage syringe is that it can reduce the number of syringes and pumps required in a diagnostic instrument. This brings down instrument costs while also reducing wash cycle times. The dual stage syringe also enables smaller instruments, as OEMs respond to market pressure to design to smaller footprints or create point-of-care machines.

Diba is currently speaking to customers about commercial applications.

About Diba
For more than 30 years, Diba Industries, Inc. has delivered precision fluid handling solutions to global OEM leaders in diagnostics, life sciences and medical devices. Diba designs and manufactures custom components across the entire system fluid path, including precision probes, fluid heaters, bonded and machined manifolds, tubing assemblies and bottle caps. Diba helps customers optimize instrument performance by minimizing carryover, improving wash characteristics and increasing system throughput and accuracy. Diba is headquartered in Danbury, CT with additional manufacturing in Berlin, CT, Cambridge, UK and Shanghai. Diba is a Halma Company. Diba is Fluid Intelligence!

View Diba's press release archive

This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.

 

SOURCE Diba Industries, Inc.


These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: